Association of serum-soluble CD26 and CD30 levels with asthma, lung function and bronchial hyper-responsiveness at school age

Acta Paediatrica, International Journal of Paediatrics

Volumn 100, Issue 9, 2011, Pages

  Remes, Sami T ^a   Delezuch, Weronika ^a,b   Pulkki, Kari ^b   Pekkanen, Juha ^b,c   Korppi, Matti ^d   Matinlauri, Irma H ^e  

^a KUOPIO UNIVERSITY HOSPITAL   (Finland)

^b UNIVERSITY OF EASTERN FINLAND   (Finland)

^c NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^d TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^e TURKU UNIVERSITY HOSPITAL   (Finland)

Author keywords

Asthma; Serum soluble CD26; Serum soluble CD30

Indexed keywords

CD30 ANTIGEN; DIPEPTIDYL PEPTIDASE IV; METHACHOLINE;

ARTICLE; ASTHMA; BRONCHUS HYPERREACTIVITY; CHILD; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC VALUE; EARLY DIAGNOSIS; EXERCISE TEST; EXPIRATORY FLOW; FEMALE; HUMAN; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROVOCATION TEST; RUNNING; SCHOOL CHILD; SPIROMETRY; TH1 TH2 BALANCE;

ADOLESCENT; AGE FACTORS; AIRWAY RESISTANCE; ANALYSIS OF VARIANCE; ANTIGENS, CD30; ASTHMA; BIOLOGICAL MARKERS; BRONCHIAL HYPERREACTIVITY; CASE-CONTROL STUDIES; CHILD; DIPEPTIDYL PEPTIDASE 4; FEMALE; HUMANS; LUNG; MALE; MULTIVARIATE ANALYSIS; QUESTIONNAIRES; SPIROMETRY; STATISTICS, NONPARAMETRIC; TH1 CELLS;

EID: 80051868866     PISSN: 08035253     EISSN: 16512227     Source Type: Journal    
DOI: 10.1111/j.1651-2227.2011.02264.x     Document Type: Article

References (23)

1. Dodig S, Richter D, Zrinski-Topic R,. Inflammatory markers in childhood asthma. Clin Chem Lab Med 2011; 49 [Epub ahead of print].
2. Szabo SJ, Sullivan BM, Peng SL, Glimcher LH,. Molecular mechanisms regulating Th1 immune responses. Annu Rev Immunol 2003; 21: 713-58. (Pubitemid 37174546)
3. Ansel KM, Djuretic I, Tanasa B, Rao A,. Regulation of Th2 differentiation and Il4 locus accessibility. Annu Rev Immunol 2006; 24: 607-56.
4. Douwes J, Gibson P, Pekkanen J, Pearce N,. Non-eosinophilic asthma: importance and possible mechanisms. Thorax 2002; 57: 643-8. (Pubitemid 34761769)
5. Ohnuma K, Yamochi T, Hosono O, Morimoto C,. CD26+ T cells in the pathogenesis of asthma. Clin Exp Immunol 2005; 139: 13-6.
6. Liao YR, Po-Yen C, Lin CC, Fu LS, Chiu CC, Chi CS,. Soluble CD26/CD30 levels before and after treatment with interferon-alpha and ribavirin combination therapy in a pediatric hepatitis C patient. J Microbiol Immunol Infect 2004; 37: 67-70. (Pubitemid 38478618)
7. Romagnani S, Del Prete G, Maggi E, Chilosi M, Caligaris-Cappio F, Pizzolo G,. CD30 and type 2 T helper (Th2) responses. J Leukoc Biol 1995; 57: 726-30.
8. Pellegrini P, Berghella AM, Contasta I, Adorno D,. CD30 antigen: not a physiological marker for TH2 cells but an important costimulator molecule in the regulation of the balance between Th1/Th2 response. Transpl Immunol 2003; 12: 49-61.
9. Lombardi V, Singh AK, Akbari O,. The role of costimulatory molecules in allergic disease and asthma. Int Arch Allergy Immunol 2010; 151: 179-89.
10. Lun SWM, Wong CK, Ko FWS, Hui DSC, Lam CWK,. Increased expression of plasma and CD4+ T lymphocyte costimulatory molecule CD26 in adult patients with allergic asthma. J Clin Immunol 2007; 27: 430-7. (Pubitemid 46906661)
11. Van der Velden VHJ, Hulsman AR,. Peptidases: structure, function and modulation of peptide-mediated effects in the human lung. Clin Exp Allergy 1999; 29: 445-56. (Pubitemid 29179813)
12. Kruschinski C, Skripuletz T, Bedoui S, Tschernig T, Pabst R, Nassenstein C, et al., CD26 (dipeptidylpeptidase IV)-dependent recruitment of T cells in a rat asthma model. Clin Exp Immunol 2005; 139: 17-24. (Pubitemid 40066124)
13. Heshmat NM, El-Hadidi ES,. Soluble CD30 serum levels in atopic dermatitis and bronchial asthma and its relationship with disease severity in pediatric age. Pediatr Allergy Immunol 2006; 17: 297-303. (Pubitemid 43873590)
14. Remes ST, Pekkanen J, Remes K, Salonen RO, Korppi M,. In search of childhood asthma: questionnaire, tests of bronchial hyperresponsiveness, and clinical evaluation. Thorax 2002; 57: 120-6. (Pubitemid 34123884)
15. Remes S, Korppi M, Remes K, Savolainen K, Mononen I, Pekkanen J,. Serum eosinophil cationic protein (ECP) and eosinophil protein X (EPX) in childhood asthma: the influence of atopy. Pediatr Pulmonol 1998; 25: 167-74. (Pubitemid 28163300)
16. Skripuletz T, Schmiedl A, Schade J, et al., Dose-dependent recruitment of CD25+ and CD26+ T cells in a novel F344 rat model of asthma. Am J Physiol Lung Cell Mol Physiol 2007; 292: L1564-71. (Pubitemid 47077372)
17. Schade J, Schmiedl A, Kehlen A, et al., Airway-specific recruitment of T cells is reduced in a CD26-deficient F344 rat substrain. Clin Exp Immunol 2009; 158: 133-42.
18. Rojas-Ramos E, Garfias Y, Jiménez-Martínez Mdel C, et al., Increased expression of CD30 and CD57 molecules on CD4(+) T cells from children with atopic asthma: a preliminary report. Allergy Asthma Proc 2007; 28: 659-66.
19. Frezzolini A, Paradisi M, Ruffelli M, Cadoni S, De Pità O,. Soluble CD30 in pediatric patients with atopic dermatitis. Allergy 1997; 52: 106-9. (Pubitemid 27120633)
20. Katoh N, Hirano S, Suehiro M, et al., Soluble CD30 is more relevant to disease activity of atopic dermatitis than soluble CD26. Clin Exp Immunol 2000; 121: 187-92. (Pubitemid 30659754)
21. Krampera M, Vinante F, Tavecchia L, et al., Progressive polarization towards a T helper/cytotoxic type-1 cytokine pattern during age-dependent maturation of the immune response inversely correlates with CD30 cell expression and serum concentration. Clin Exp Immunol 1999; 117: 291-7. (Pubitemid 29343600)
22. Chen JY, Fu LS, Chu JJ, Chen HC, Chi CS,. Plasma soluble CD30 level correlates negatively with age in children. J Microbiol Immunol Infect 2007; 40: 168-72.
23. Oflazoglu E, Simpson EL, Takiguchi R, Grewal IS, Hanifin JM, Gerber HP,. CD30 expression on CD1a+ and CD8+ cells in atopic dermatitis and correlation with disease severity. Eur J Dermatol 2008; 18: 41-9. (Pubitemid 351158171)